Breaking News

Rithem Life Sciences Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

1st Patients Enrolled in STEM Trial for `Treatment of Chronic Subdural Hematoma

This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for the treatment of chronic subdural hematoma (cSDH), a common disease affecting primarily older adults.

Genius AI Detection Receives FDA Clearance – New Deep Learning-based Software Designed to Help Radiologists Detect Subtle Potential Cancers in Breast Tomosynthesis Images

This new technology, represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius® 3D Mammography™ exam.

Passio Pump Drainage System Granted 510(k) for Additional Indication for Home Use

The Passio Pump Drainage System consists of the Passio Catheter, a Handheld Control Unit (pump) and a Disposable Collection Kit, which includes a redressing kit, for drainage of recurrent and symptomatic pleural effusion.

Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business

Boston Scientific notes SERB, backed by private equity firm Charterhouse Capital Partners since 2017, owns a diversified portfolio of prescription medicines focused on rare and life-threatening diseases.

EDM Medical Solutions Releases New Product Line Designed to Protect Patients During COVID-19

EDM Medical Solutions today announced its launch of CT scanner drapes and other medical equipment covers aimed at reducing the spread of infections in the medical environment. The single-use, sterile drapes are the latest addition to the company’s line of infection control supplies.

Since the beginning of the pandemic, EDM Medical Solutions has seen the demand for personal protective equipment (PPE) and equipment protection skyrocket. In response, the company has worked to meet the evolving needs of clinicians by rapidly adding new products to its infection control product line.

By covering medical imaging machinery with single-use drapes, practitioners can better protect themselves and patients when examining potential COVID-19 cases. These drapes act as a barrier to infection; therefore, they are effective at reducing the risk of viral transmission via equipment and other surfaces.

EDM Medical Solutions was already at the frontlines in the battle against infection transmission in the healthcare environment. Prior to the COVID-19 outbreak, there was a consensus that infection control was a priority for healthcare providers,” says Benjamin El Koubi, operations and marketing manager at EDM. “However, similar to the digital transformation, the pandemic has sped up the process and raised awareness to new levels.”

The spread of COVID-19 has led medical practitioners to seek new ways of keeping patients safe. The company notes that the use of ultrasound imaging as well as MRI and CT for the diagnosis of the virus has translated to a greater need for infection control for medical imaging. EDM’s addition of equipment drapes for CT scanners is a response to the need for better-protected medical imaging equipment as well as the challenges facing healthcare facilities as they reopen. During the current reopening phase, healthcare facilities are looking to protect pieces of equipment that would traditionally go undraped in the past.

“For instance, we witnessed a spike in demand for tablet and laptop covers as more medical practices now seek ways to minimize viral transmission through surfaces as much as possible. These devices were not protected prior to the coronavirus. The same is true regarding the new CT drapes we just launched. They were a request made by capital equipment manufacturers to our headquarters in Europe,” says El Koubi.

EDM Medical Solutions line of equipment drapes continues to be updated as medical practices adjust and refine their infection control protocols to the new climate. The CT drapes are now a part of the company’s broader assortment which includes drapes for tablets, ultrasound machines, c-arm scanners, surgical cameras, and more.

“This accelerated trend for protection and hygiene calls for the development of new products in the future,” notes El Koubi.

The new drapes have been designed to meet the quality standards of the industry. They are made of high-quality latex-free material and sterilized with ethylene oxide (EO) to maximize patient safety.

Latest Posts

Rithem Life Sciences Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

1st Patients Enrolled in STEM Trial for `Treatment of Chronic Subdural Hematoma

This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for the treatment of chronic subdural hematoma (cSDH), a common disease affecting primarily older adults.

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

Don't Miss

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials.